Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$271.54 - $344.06 $476,552 - $603,825
-1,755 Reduced 44.03%
2,231 $767,000
Q1 2023

May 12, 2023

BUY
$220.43 - $278.69 $82,220 - $103,951
373 Added 10.32%
3,986 $1.11 Million
Q4 2022

Feb 14, 2023

BUY
$151.88 - $228.5 $548,742 - $825,570
3,613 New
3,613 $802,000
Q4 2021

Feb 10, 2022

SELL
$238.08 - $288.0 $1.48 Million - $1.78 Million
-6,196 Closed
0 $0
Q3 2021

Oct 28, 2021

BUY
$250.72 - $291.24 $1.55 Million - $1.8 Million
6,196 New
6,196 $1.65 Million
Q1 2021

Jul 21, 2021

SELL
$175.6 - $291.43 $1.08 Million - $1.79 Million
-6,155 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$174.98 - $272.83 $1.13 Million - $1.76 Million
-6,444 Reduced 51.15%
6,155 $1.08 Million
Q3 2020

Oct 30, 2020

SELL
$185.27 - $238.73 $981,931 - $1.27 Million
-5,300 Reduced 29.61%
12,599 $2.45 Million
Q2 2020

Aug 05, 2020

SELL
$153.32 - $191.72 $375,480 - $469,522
-2,449 Reduced 12.04%
17,899 $3.2 Million
Q1 2020

May 11, 2020

SELL
$124.34 - $193.76 $585,765 - $912,803
-4,711 Reduced 18.8%
20,348 $3.28 Million
Q4 2019

Feb 13, 2020

BUY
$134.81 - $177.8 $2.33 Million - $3.07 Million
17,263 Added 221.43%
25,059 $4.12 Million
Q3 2019

Nov 08, 2019

BUY
$131.82 - $183.4 $1.03 Million - $1.43 Million
7,796 New
7,796 $1.05 Million
Q2 2019

Jul 08, 2019

SELL
$124.65 - $167.39 $238,580 - $320,384
-1,914 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$115.84 - $160.31 $22,357 - $30,939
193 Added 11.21%
1,914 $281,000
Q4 2018

Feb 05, 2019

SELL
$113.42 - $156.48 $52,626 - $72,606
-464 Reduced 21.24%
1,721 $210,000
Q3 2018

Nov 02, 2018

SELL
$121.55 - $156.8 $50,929 - $65,699
-419 Reduced 16.09%
2,185 $0
Q2 2018

Aug 20, 2018

BUY
$112.2 - $165.95 $26,591 - $39,330
237 Added 10.01%
2,604 $0
Q1 2018

May 21, 2018

BUY
$84.6 - $126.1 $200,248 - $298,478
2,367 New
2,367 $0

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.11B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.